Primary Record
Tavaborole
- In stock
- 1,270 g
- Purity
- 98.1 %
- CAS
- 174671-46-6
Compound Identifiers & Properties
- CAS
- 174671-46-6
- PubChem CID
- 11499245
- SMILES
- B1(C2=C(CO1)C=C(C=C2)F)O
- Canonical SMILES
- OB1OCc2cc(F)ccc21
Names & Synonyms
- Tavaborole
- Kerydin
- 174671-46-6
- AN-2690
- tavaborol
- 5-FLUOROBENZO[C][1,2]OXABOROL-1(3H)-OL
- tavaborolum
- Tavaborole [USAN]
- p-fluorbenzoxaborole
- AN2690
- Kerydin (TN)
- Tavaborole (USAN)
- C7H6BFO2
- Tavaborole [USAN:INN]
- Tavaborole (>90%)
- RefChem:58437
- TAVABOROLE [MI]
- AN 2690
- TAVABOROLE [INN]
- 2,1-Benzoxaborole, 5-fluoro-1,3-dihydro-1-hydroxy-
- AN-2690(Tavaborole)
- K124A4EUQ3
- UNII-K124A4EUQ3
- 5-fluoro-1-hydroxy-3H-2,1-benzoxaborole
- MFCD10699483
- TAVABOROLE [VANDF]
- D05VGL
- Tavaborole (AN-2690)
- SCH-900340
- 5-fluoro-2,1-benzoxaborol-1(3H)-ol
- TAVABOROLE [WHO-DD]
- CHEBI:77942
- SCHEMBL500016
- DTXSID00169888
- CHEMBL443052
- orb1304296
- DTXCID5092379
- SCH 900340
- SCHEMBL29372574
- TAVABOROLE [ORANGE BOOK]
- CTK8H2675
- HSDB 8342
- KS-00000SPV
- 5-Fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole
- D01AE24
- 5-fluoro-1,3-dihydro-2,1-benzoxaborol-1-ol
- LFQDNHWZDQTITF-UHFFFAOYSA-N
- AIDS471673
- GLXC-05353
- HMS5084K07
- TAVABOROLE topical solution, 5%
- BCP08730
- EX-A1086
- 3338AH
- BDBM50370987
- EBC-03407
- s4996
- AKOS006303927
- ZINC169990691
- ACN-037992
- CCG-266215
- CS-1058
- DB09041
- DS-8392
- MB08883
- CID11499245
- 5-Fluoro-1-hydroxy-2,1-benzoxaborolane
- NCGC00264110-01
- NCGC00264110-02
- AC-30887
- AK163946
- AN-2690)
- HY-10980
- SY038332
- 1,3-dihydro-5-fluoro-1-hydroxy-2,1-benzoxaborole
- 5-Fluoro-3H-benzo[c][1,2)oxaborol-1-ol
- 5-fluoro-3H-benzo[c][1,2]oxaborol-1-ol
- 5-Fluorobenzo[c][1,2]oxaboro-1(3H)-ol
- DB-100333
- A3177
- FT-0697827
- NS00073562
- ST24044751
- T3775
- X3699
- J2.495.581H
- A14999
- D10169
- EN300-125084
- F11396
- Topical antifungal (onychomycosis), Merck & Co
- W-5454
- 5-Fluoro-1,3-dihydro-2,1-benzooxaborole-1-ol
- 5-Fluoro-1-bora-1,3-dihydroisobenzofuran-1-ol
- A855852
- F425086
- 5-Fluoro-1,3-dihydro-1-hydroxy-2,1-benzooxaborole
- BRD-K76713213-001-01-3
- BRD-K76713213-001-02-1
- Q21011226
- 5-Fluoro-1-hydroxyl-1,3-dihydrobenzo[c][1,2]oxaborole
- Z1198279578
- Trichophyton-targeting antifungal (onychomycosis), Merck & Co
- Fungal leucyl-tRNA synthetase inhibitor (onychomycosis), Merck & Co/Anacor
- Trichophyton-targeting antifungal (onychomycosis), Anacor Pharmaceuticals/Schering-Plough
- 2,1-Benzoxaborole, 5-fluoro-1,3-dihydro-1-hydroxy-; 5-Fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole; 5-Fluoro-1,3-dihydro-2,1-benzoxaborol-1-ol; AN 2690; AN 2729; Kerydin; Tavaborole
- AN 2690; AN 2729; Kerydin; 5-Fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole; 5-Fluoro-1,3-dihydro-2,1-benzoxaborol-1-ol
- Fungal leucyl-tRNA synthetase inhibitor (onychomycosis), Anacor Pharmaceuticals/Schering-Plough